Ipsen (IPSEF) Other Current Receivables : $0 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Ipsen Other Current Receivables?

Ipsen's Other Current Receivables for the quarter that ended in Dec. 2024 was $0 Mil.

Ipsen's annual Other Current Receivables declined from Dec. 2022 ($40.57 Mil) to Dec. 2023 ($0.00 Mil) but then stayed the same from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil).

Ipsen Other Current Receivables Historical Data

The historical data trend for Ipsen's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Other Current Receivables Chart

Ipsen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Receivables

Get a 7-Day Free Trial

27.25

26.44

40.57

Ipsen Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Current Receivables	Get a 7-Day Free Trial															40.57	-	-	-	-

Ipsen Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Ipsen Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Ipsen's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipsen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (OTCPK:IPSEF) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

IPSEY:USA IPNp:UK 0MH6:UK IPN:France I7G:Germany IPN:Austria

Address

70 rue Balard, Paris, FRA, 75015

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.